Aethlon Medical (AEMD) Total Debt (QoQ) (2011 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Aethlon Medical | 1.14 Mn | -5.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 12.51% |
| Dec 31, 2022 | 7.25% |
| Sep 30, 2022 | 9.55% |
| Jun 30, 2022 | 4.05% |
| Mar 31, 2022 | 19.46% |
| Dec 31, 2021 | -2.86% |
| Sep 30, 2021 | 12.23% |
| Jun 30, 2021 | -23.22% |
| Mar 31, 2021 | 18.21% |
| Dec 31, 2020 | -16.04% |
| Sep 30, 2020 | 19.01% |
| Jun 30, 2020 | 18.03% |
| Mar 31, 2020 | 0.45% |
| Dec 31, 2019 | 9.61% |
| Sep 30, 2019 | 7.43% |
| Jun 30, 2019 | 12.90% |
| Mar 31, 2019 | 19.93% |
| Dec 31, 2018 | -29.45% |
| Sep 30, 2018 | 9.41% |
| Jun 30, 2018 | 0.00% |
| Mar 31, 2018 | 40.18% |
| Dec 31, 2017 | 32.60% |
| Sep 30, 2017 | 0.52% |
| Jun 30, 2017 | -16.42% |
| Mar 31, 2017 | -0.85% |
| Dec 31, 2016 | 0.00% |
| Sep 30, 2016 | 106.59% |
| Jun 30, 2016 | -80.53% |
| Mar 31, 2016 | -6.45% |
| Dec 31, 2015 | -24.01% |
| Sep 30, 2015 | 16.56% |
| Jun 30, 2015 | 19.85% |
| Mar 31, 2015 | -81.97% |
| Jun 30, 2014 | -92.34% |
| Mar 31, 2014 | 1,261.14% |
| Dec 31, 2013 | -86.62% |
| Sep 30, 2013 | 634.20% |
| Jun 30, 2013 | -77.74% |
| Mar 31, 2013 | 388.81% |
| Dec 31, 2012 | -77.02% |
| Sep 30, 2012 | 11.13% |
| Jun 30, 2012 | 293.73% |
| Mar 31, 2012 | 18.22% |
| Dec 31, 2011 | 0.00% |
| Sep 30, 2011 | -72.20% |
| Jun 30, 2011 | 10.90% |